Laser resurfacing is not a stronger serum.
It is controlled injury.
That is the first decision point. If the problem is dryness, mild dullness, a damaged barrier, or untreated melasma, the answer may be skin care and diagnosis first. If the problem is stable photoaging, etched wrinkles, texture, pores, or selected scars, a fractional laser discussion may fit.
In a randomized split-face study, 18 patients with a mean age of 55.9 completed treatment comparing three sessions of nonablative 1540-nm fractional Erbium laser on one side of the face with one session of ablative 2940-nm Erbium laser on the other. All patients improved clinically, with no significant difference between sides at 3 months. [1]
That is useful evidence.
It is also a reminder that settings, device type, number of sessions, and follow-up length matter.
Ablative and nonablative are different choices
Ablative fractional lasers remove tiny columns of epidermis and heat deeper tissue. Nonablative fractional lasers heat targeted columns while leaving the surface more intact. That simplified distinction drives much of the tradeoff: recovery, wound care, pigment risk, and sometimes magnitude of resurfacing.
A study in photoaged Asian skin compared ablative fractional Er:YAG laser with nonablative fractional Er:glass laser. Pigmentation and uneven tone improved more after the ablative Er:YAG treatment, while wrinkle score improved more after the nonablative Er:glass treatment. [2]
That is not a simple "stronger is better" story.
For a woman after menopause, the best device depends on the main problem: wrinkles, pigment, pores, texture, laxity, melasma risk, downtime tolerance, skin type, past pigment reactions, and whether the operator can adjust settings safely.
What the trials actually support
Some trials are small. A prospective carbon-dioxide laser photoaging study had 10 subjects and reported improvements in dyschromia, texture, laxity, rhytides, and overall appearance at 6 months, but small study size and procedure context limit broad promises. [5]
A randomized controlled trial of 22 people with Fitzpatrick phototypes II to III compared fractional CO2 alone with fractional CO2 plus rhodamine-intense pulsed light. The combination group had shorter healing time, about 7.8 days versus 13.8 days, and a greater wrinkle-severity reduction, but this was still a small procedural study. [3]
A split-face trial in 15 Chinese patients compared microneedle fractional radiofrequency with nonablative 1565-nm fractional laser. Both sides improved facial photoaging measures; the nonablative laser side had shorter downtime than the microneedle radiofrequency side. [4]
A newer nonablative 1440-nm and 1927-nm combination-laser study enrolled 28 participants, 89% female, with mild-to-moderate photoaged skin. Four monthly treatments improved measured photodamage at 1 and 3 months, with no serious adverse events reported. [6]
Together, the evidence supports fractional lasers as legitimate photoaging tools. The evidence is limited by device variability, small samples, short follow-up, operator dependence, and the fact that "laser" is not one treatment.
Pigment risk is part of the procedure
Laser injury can trigger post-inflammatory hyperpigmentation.
That risk matters more when skin is pigment-prone, recently tanned, melasma-prone, inflamed, or not protected from UV and visible light. But the exact risk is not easy to reduce to one number. A review of post-inflammatory hyperpigmentation after CO2 laser treatment found that incidence varied substantially across studies and that available studies were not high-powered enough to settle all risk-factor questions. [7]
A broader 2024 systematic review of PIH in skin of color included 48 studies and 1,356 participants. Laser therapy was reported frequently; partial improvement occurred in many patients, but cases of PIH exacerbation after laser were also reported. [8]
That is why pigment risk should be discussed before the procedure, not after brown patches appear.
Comparison table: choose the procedure by the problem
| Main goal | Possible procedure category | What to clarify first |
|---|---|---|
| Fine lines and texture | Nonablative fractional laser, ablative fractional laser, microneedling, retinoid plan, or no procedure. | Expected sessions, irritation, downtime, and realistic magnitude of improvement. |
| Deeper photoaging and etched wrinkles | Ablative fractional laser may be considered in selected patients. | Healing time, infection prevention, pigment risk, scarring risk, and operator experience. |
| Pigment and uneven tone | Device choice depends on skin type, melasma risk, and diagnosis. | Whether pigment is melasma, lentigines, PIH, actinic damage, or a lesion needing exam. |
| Darker or pigment-prone skin | More conservative settings, nonablative options, test spots, or non-laser options may fit better. | PIH prevention, pre/post-care, and what happens if pigment worsens. |
| Low downtime priority | Nonablative laser, topical plan, or no procedure may be a better fit. | Number of sessions, indirect cost, social downtime, and expected result durability. |
| Active rash, acne flare, wound, infection, or barrier injury | Defer procedure. | Diagnose and calm inflammation first. |
What to settle before booking
| Decision | Why it matters |
|---|---|
| Diagnosis | Lasers for photoaging, melasma, scars, redness, lentigines, and actinic damage are not interchangeable. |
| Device and wavelength | "Fractional laser" is too vague; the device drives depth, heat, downtime, and risk. |
| Ablative versus nonablative | Ablative may mean more resurfacing and more wound care; nonablative may mean less downtime and more sessions. |
| Skin type and pigment history | Fitzpatrick type, melasma, PIH history, tanning, and recent inflammation affect risk. |
| Pre-care and post-care | Sunscreen, antiviral plan when relevant, wound care, and irritant avoidance affect recovery. |
| Operator plan | Settings, test spots, adverse-event plan, and follow-up should be explicit. |
| Cost of the full course | One session is different from a series plus maintenance and recovery time. |
A structured skin assessment can separate photoaging from melasma, PIH, rosacea, acne scarring, actinic keratoses, and lesions needing diagnosis before choosing laser, microneedling, retinoids, pigment therapy, or watchful waiting.
Who this fits, and who should avoid a shortcut
Fractional laser may fit a woman with stable photoaging concerns, realistic downtime tolerance, consistent sunscreen use, and a clinician or experienced proceduralist who can match device and settings to skin type.
It is a poorer fit when pigment is active, melasma is unstable, recent tanning occurred, barrier inflammation is present, an infection or wound is present, isotretinoin or wound-healing concerns apply, or the patient needs a no-downtime cosmetic product rather than a procedure. It is also a poor fit when the clinic cannot explain pigment-risk prevention, expected healing, emergency contact, or what happens if pigment worsens.
The goal is not to find the strongest laser. The goal is to choose the least aggressive procedure that has a realistic chance of improving the diagnosed problem.
Red flags before laser
Pause before laser when there is a changing mole, bleeding lesion, nonhealing rough patch, suspected actinic keratosis or skin cancer, active infection, active eczema or dermatitis, recent sunburn or tanning, unstable melasma, recent aggressive peel, unexplained pigment change, history of abnormal scarring, immune suppression, or inability to follow sun avoidance and wound care.
Also pause when the consultation cannot answer basic questions: device, wavelength, settings philosophy, downtime, adverse effects, pigment prevention, aftercare, and who manages complications.
What to ask a clinician
Ask:
- Is my main target wrinkles, texture, pigment, scars, redness, pores, or laxity?
- Is the pigment melasma, lentigines, PIH, actinic damage, or a lesion that needs exam?
- Which device and wavelength are being used, and why does it fit my skin type?
- Is this ablative or nonablative, and how does that change downtime and risk?
- What is my post-inflammatory hyperpigmentation risk?
- What downtime, wound care, sun avoidance, and infection precautions are expected?
- What result is realistic after one session versus a series?
- What is the plan if pigment worsens, healing is delayed, or infection signs appear?
Bottom line
Fractional laser can be a strong option for selected photoaging concerns after menopause.
It should be treated like a medical-cosmetic procedure, not an impulse purchase.
Ask what the diagnosis is, which device is being used, whether the goal is pigment or wrinkles, what downtime is expected, how pigment risk is controlled, and what daily sunscreen/barrier routine protects the result.
Related reading:
- Hydroquinone and TRI-LUMA for Melasma After Menopause.
- Retinol vs Tretinoin After Menopause.
- Laser for Melasma After Menopause.
- Rough Sun Spots After Menopause.
References
[1] Borges J, Cuzzi T, Mandarim-de-Lacerda CA, Manela-Azulay M. Fractional Erbium laser in the treatment of photoaging: randomized comparative, clinical and histopathological study of ablative (2940nm) vs. non-ablative (1540nm) methods after 3 months. An Bras Dermatol. 2014;89(2):250-8. doi:10.1590/abd1806-4841.20142370 https://pubmed.ncbi.nlm.nih.gov/24770501/
[2] Moon HR, Yun WJ, Lee YJ, Lee MW, Chang S. A prospective, randomized, double-blind comparison of an ablative fractional 2940-nm erbium-doped yttrium aluminum garnet laser with a nonablative fractional 1550-nm erbium-doped glass laser for the treatment of photoaged Asian skin. J Dermatolog Treat. 2015;26(6):551-7. doi:10.3109/09546634.2014.999020 https://pubmed.ncbi.nlm.nih.gov/26417998/
[3] Nistico SP, Silvestri M, Zingoni T, Tamburi F, Bennardo L, Cannarozzo G. Combination of Fractional CO(2) Laser and Rhodamine-Intense Pulsed Light in Facial Rejuvenation: A Randomized Controlled Trial. Photobiomodul Photomed Laser Surg. 2021;39(2):113-117. doi:10.1089/photob.2020.4876 https://pubmed.ncbi.nlm.nih.gov/33449867/
[4] Dou W, Yang Q, Yin Y, et al. Fractional microneedle radiofrequency device and fractional erbium-doped glass 1,565-nm device treatment of human facial photoaging: a prospective, split-face, random clinical trial. J Cosmet Laser Ther. 2021;23(5-6):142-148. doi:10.1080/14764172.2022.2033783 https://pubmed.ncbi.nlm.nih.gov/35083965/
[5] Tierney EP, Hanke CW, Petersen J. Ablative fractionated CO2 laser treatment of photoaging: a clinical and histologic study. Dermatol Surg. 2012;38(11):1777-89. doi:10.1111/j.1524-4725.2012.02572.x https://pubmed.ncbi.nlm.nih.gov/23110481/
[6] Polder KD, Friedman PM, Feetham J, Gower J, Lin T, Jacobson A. Nonablative Fractional Diode Laser Resurfacing (1440 nm and 1927 nm) for Photoaged Skin. Dermatol Surg. 2025;51(1):52-57. doi:10.1097/dss.0000000000004379 https://pubmed.ncbi.nlm.nih.gov/39190540/
[7] Bin Dakhil A, Shadid A, Altalhab S. Post-inflammatory hyperpigmentation after carbon dioxide laser: review of prevention and risk factors. Dermatol Reports. 2023;15(4):9703. doi:10.4081/dr.2023.9703 https://pubmed.ncbi.nlm.nih.gov/38205425/
[8] Mar K, Khalid B, Maazi M, Ahmed R, Wang OJE, Khosravi-Hafshejani T. Treatment of Post-Inflammatory Hyperpigmentation in Skin of Colour: A Systematic Review. J Cutan Med Surg. 2024;28(5):473-480. doi:10.1177/12034754241265716 https://pubmed.ncbi.nlm.nih.gov/39075672/